Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This change does not alter study content or user-facing features.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous government funding lapse notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a notice about a lapse in government funding and the NIH Clinical Center's operating status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check91 days agoChange DetectedAdd glossary display and new QC/label elements: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data' capitalization, and 'Revision: v3.4.0'. Deletions remove the older lowercase labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' along with the older 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.